APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Eosinophilic Esophagitis Drug

Eosinophilic esophagitis (EoE, also spelled eosinophilic oesophagitis), also known as allergic oesophagitis, is an allergic inflammatory condition of the esophagus that involves eosinophils, a type of white blood cell. Symptoms are swallowing difficulty, food impaction, vomiting, and heartburn.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Eosinophilic esophagitis (EoE, also spelled eosinophilic oesophagitis), also known as allergic oesophagitis, is an allergic inflammatory condition of the esophagus that involves eosinophils, a type of white blood cell. Symptoms are swallowing difficulty, food impaction, vomiting, and heartburn.

Eosinophilic esophagitis was first described in children but also occurs in adults. The condition is not well understood, but food allergy may play a significant role. The treatment may consist of removal of known or suspected triggers and medication to suppress the immune response.

This report studies the eosinophilic esophagitis drug market.

Selected research

Market Analysis & Forecast

Global Eosinophilic Esophagitis Drug Market Analysis and Forecast 2026-2032

Report ID 173988720226 December 2025199 pages

Choose your research edition.

Industry ResearchEosinophilic Esophagitis Drug Industry Research Report 2026122 pages · $2,950 USDIndustry Growth & TrendsGlobal Eosinophilic Esophagitis Drug Industry Growth and Trends Forecast to 2032104 pages · $3,450 USDMarket StructureGlobal Eosinophilic Esophagitis Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Eosinophilic Esophagitis Drug Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Eosinophilic Esophagitis Drug Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

Eosinophilic esophagitis (EoE, also spelled eosinophilic oesophagitis), also known as allergic oesophagitis, is an allergic inflammatory condition of the esophagus that involves eosinophils, a type of white blood cell. Symptoms are swallowing difficulty, food impaction, vomiting, and heartburn.

Eosinophilic esophagitis was first described in children but also occurs in adults. The condition is not well understood, but food allergy may play a significant role. The treatment may consist of removal of known or suspected triggers and medication to suppress the immune response.

This report studies the eosinophilic esophagitis drug market.

Read the full market overview

AstraZeneca, GSK and Bayer are the leading producers of eosinophilic esophagitis drug, which together account for about 80% of the market.

North America is the leading region, accounting for more than 30% of the market, followed by Europe at nearly 30%.

This report presents an overview of global market for Eosinophilic Esophagitis Drug, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Eosinophilic Esophagitis Drug, also provides the sales of main regions and countries. Of the upcoming market potential for Eosinophilic Esophagitis Drug, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Eosinophilic Esophagitis Drug sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Eosinophilic Esophagitis Drug market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Eosinophilic Esophagitis Drug sales, projected growth trends, production technology, application and end-user industry.

Eosinophilic Esophagitis Drug Segment by Company

AstraZeneca

GSK

Bayer

Adare Pharmaceuticals

DBV Technologies

Dr. Falk Pharma

Quorum Innovations

Takeda

Calypso

Celgene

Regeneron

Eosinophilic Esophagitis Drug Segment by Type

Budesonide

Fluticasone

Others

Eosinophilic Esophagitis Drug Segment by Application

Hospitals

Clinics

Drugstore

Eosinophilic Esophagitis Drug Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Eosinophilic Esophagitis Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Eosinophilic Esophagitis Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Eosinophilic Esophagitis Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Eosinophilic Esophagitis Drug in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Eosinophilic Esophagitis Drug manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Eosinophilic Esophagitis Drug sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Eosinophilic Esophagitis Drug Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Budesonide Major Manufacturers Table 3. Fluticasone Major Manufacturers Table 4. Others Major Manufacturers Table 5. Global Eosinophilic Esophagitis Drug Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Hospitals Major Manufacturers Table 7. Clinics Major Manufacturers Table 8. Drugstore Major Manufacturers Table 9. Eosinophilic Esophagitis Drug Industry Trends Table 10. Eosinophilic Esophagitis Drug Industry Drivers Table 11. Eosinophilic Esophagitis Drug Industry Opportunities and Challenges Table 12. Eosinophilic Esophagitis Drug Industry Restraints Table 13. Global Eosinophilic Esophagitis Drug Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 14. Global Eosinophilic Esophagitis Drug Revenue by Region (2021-2026) & (US$ Million) Table 15. Global Eosinophilic Esophagitis Drug Revenue by Region (2027-2032) & (US$ Million) Table 16. Global Eosinophilic Esophagitis Drug Revenue Market Share by Region (2021-2026) Table 17. Global Eosinophilic Esophagitis Drug Revenue Market Share by Region (2027-2032) Table 18. Global Eosinophilic Esophagitis Drug Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 19. Global Eosinophilic Esophagitis Drug Sales by Region (2021-2026) & (K Units) Table 20. Global Eosinophilic Esophagitis Drug Sales by Region (2027-2032) & (K Units) Table 21. Global Eosinophilic Esophagitis Drug Sales Market Share by Region (2021-2026) Table 22. Global Eosinophilic Esophagitis Drug Sales Market Share by Region (2027-2032) Table 23. Global Eosinophilic Esophagitis Drug Revenue by Manufacturers (US$ Million) & (2021-2026) Table 24. Global Eosinophilic Esophagitis Drug Revenue Market Share by Manufacturers (2021-2026) Table 25. Global Eosinophilic Esophagitis Drug Sales by Manufacturers (US$ Million) & (2021-2026) Table 26. Global Eosinophilic Esophagitis Drug Sales Market Share by Manufacturers (2021-2026) Table 27. Global Eosinophilic Esophagitis Drug Sales Price (USD/Unit) of Manufacturers (2021-2026) Table 28. Global Eosinophilic Esophagitis Drug Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 29. Global Eosinophilic Esophagitis Drug Key Manufacturers Manufacturing Sites & Headquarters Table 30. Global Eosinophilic Esophagitis Drug Manufacturers, Product Type & Application Table 31. Global Eosinophilic Esophagitis Drug Manufacturers' Establishment Date Table 32. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 33. Global Eosinophilic Esophagitis Drug by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 34. Global Eosinophilic Esophagitis Drug Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Eosinophilic Esophagitis Drug Revenue by Type (2021-2026) & (US$ Million) Table 36. Global Eosinophilic Esophagitis Drug Revenue by Type (2027-2032) & (US$ Million) Table 37. Global Eosinophilic Esophagitis Drug Revenue Market Share by Type (2021-2026) Table 38. Global Eosinophilic Esophagitis Drug Revenue Market Share by Type (2027-2032) Table 39. Global Eosinophilic Esophagitis Drug Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 40. Global Eosinophilic Esophagitis Drug Sales by Type (2021-2026) & (K Units) Table 41. Global Eosinophilic Esophagitis Drug Sales by Type (2027-2032) & (K Units) Table 42. Global Eosinophilic Esophagitis Drug Sales Market Share by Type (2021-2026) Table 43. Global Eosinophilic Esophagitis Drug Sales Market Share by Type (2027-2032) Table 44. Global Eosinophilic Esophagitis Drug Price by Type (2021-2026) & (USD/Unit) Table 45. Global Eosinophilic Esophagitis Drug Price by Type (2027-2032) & (USD/Unit) Table 46. Global Eosinophilic Esophagitis Drug Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Eosinophilic Esophagitis Drug Revenue by Application (2021-2026) & (US$ Million) Table 48. Global Eosinophilic Esophagitis Drug Revenue by Application (2027-2032) & (US$ Million) Table 49. Global Eosinophilic Esophagitis Drug Revenue Market Share by Application (2021-2026) Table 50. Global Eosinophilic Esophagitis Drug Revenue Market Share by Application (2027-2032) Table 51. Global Eosinophilic Esophagitis Drug Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 52. Global Eosinophilic Esophagitis Drug Sales by Application (2021-2026) & (K Units) Table 53. Global Eosinophilic Esophagitis Drug Sales by Application (2027-2032) & (K Units) Table 54. Global Eosinophilic Esophagitis Drug Sales Market Share by Application (2021-2026) Table 55. Global Eosinophilic Esophagitis Drug Sales Market Share by Application (2027-2032) Table 56. Global Eosinophilic Esophagitis Drug Price by Application (2021-2026) & (USD/Unit) Table 57. Global Eosinophilic Esophagitis Drug Price by Application (2027-2032) & (USD/Unit) Table 58. AstraZeneca Company Information Table 59. AstraZeneca Business Overview Table 60. AstraZeneca Eosinophilic Esophagitis Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 61. AstraZeneca Eosinophilic Esophagitis Drug Product Portfolio Table 62. AstraZeneca Recent Development Table 63. GSK Company Information Table 64. GSK Business Overview Table 65. GSK Eosinophilic Esophagitis Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 66. GSK Eosinophilic Esophagitis Drug Product Portfolio Table 67. GSK Recent Development Table 68. Bayer Company Information Table 69. Bayer Business Overview Table 70. Bayer Eosinophilic Esophagitis Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 71. Bayer Eosinophilic Esophagitis Drug Product Portfolio Table 72. Bayer Recent Development Table 73. Adare Pharmaceuticals Company Information Table 74. Adare Pharmaceuticals Business Overview Table 75. Adare Pharmaceuticals Eosinophilic Esophagitis Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 76. Adare Pharmaceuticals Eosinophilic Esophagitis Drug Product Portfolio Table 77. Adare Pharmaceuticals Recent Development Table 78. DBV Technologies Company Information Table 79. DBV Technologies Business Overview Table 80. DBV Technologies Eosinophilic Esophagitis Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 81. DBV Technologies Eosinophilic Esophagitis Drug Product Portfolio Table 82. DBV Technologies Recent Development Table 83. Dr. Falk Pharma Company Information Table 84. Dr. Falk Pharma Business Overview Table 85. Dr. Falk Pharma Eosinophilic Esophagitis Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 86. Dr. Falk Pharma Eosinophilic Esophagitis Drug Product Portfolio Table 87. Dr. Falk Pharma Recent Development Table 88. Quorum Innovations Company Information Table 89. Quorum Innovations Business Overview Table 90. Quorum Innovations Eosinophilic Esophagitis Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 91. Quorum Innovations Eosinophilic Esophagitis Drug Product Portfolio Table 92. Quorum Innovations Recent Development Table 93. Takeda Company Information Table 94. Takeda Business Overview Table 95. Takeda Eosinophilic Esophagitis Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 96. Takeda Eosinophilic Esophagitis Drug Product Portfolio Table 97. Takeda Recent Development Table 98. Calypso Company Information Table 99. Calypso Business Overview Table 100. Calypso Eosinophilic Esophagitis Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 101. Calypso Eosinophilic Esophagitis Drug Product Portfolio Table 102. Calypso Recent Development Table 103. Celgene Company Information Table 104. Celgene Business Overview Table 105. Celgene Eosinophilic Esophagitis Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 106. Celgene Eosinophilic Esophagitis Drug Product Portfolio Table 107. Celgene Recent Development Table 108. Regeneron Company Information Table 109. Regeneron Business Overview Table 110. Regeneron Eosinophilic Esophagitis Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 111. Regeneron Eosinophilic Esophagitis Drug Product Portfolio Table 112. Regeneron Recent Development Table 113. North America Eosinophilic Esophagitis Drug Revenue by Type (2021-2026) & (US$ Million) Table 114. North America Eosinophilic Esophagitis Drug Revenue by Type (2027-2032) & (US$ Million) Table 115. North America Eosinophilic Esophagitis Drug Sales by Type (2021-2026) & (K Units) Table 116. North America Eosinophilic Esophagitis Drug Sales by Type (2027-2032) & (K Units) Table 117. North America Eosinophilic Esophagitis Drug Sales Price by Type (2021-2026) & (USD/Unit) Table 118. North America Eosinophilic Esophagitis Drug Sales Price by Type (2027-2032) & (USD/Unit) Table 119. North America Eosinophilic Esophagitis Drug Revenue by Application (2021-2026) & (US$ Million) Table 120. North America Eosinophilic Esophagitis Drug Revenue by Application (2027-2032) & (US$ Million) Table 121. North America Eosinophilic Esophagitis Drug Sales by Application (2021-2026) & (K Units) Table 122. North America Eosinophilic Esophagitis Drug Sales by Application (2027-2032) & (K Units) Table 123. North America Eosinophilic Esophagitis Drug Sales Price by Application (2021-2026) & (USD/Unit) Table 124. North America Eosinophilic Esophagitis Drug Sales Price by Application (2027-2032) & (USD/Unit) Table 125. North America Eosinophilic Esophagitis Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 126. North America Eosinophilic Esophagitis Drug Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 127. North America Eosinophilic Esophagitis Drug Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 128. North America Eosinophilic Esophagitis Drug Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 129. North America Eosinophilic Esophagitis Drug Sales by Country (2021-2026) & (K Units) Table 130. North America Eosinophilic Esophagitis Drug Sales by Country (2027-2032) & (K Units) Table 131. North America Eosinophilic Esophagitis Drug Sales Price by Country (2021-2026) & (USD/Unit) Table 132. North America Eosinophilic Esophagitis Drug Sales Price by Country (2027-2032) & (USD/Unit) Table 133. United States Eosinophilic Esophagitis Drug Revenue (2021-2032) & (US$ Million) Table 134. Canada Eosinophilic Esophagitis Drug Revenue (2021-2032) & (US$ Million) Table 135. Mexico Eosinophilic Esophagitis Drug Revenue (2021-2032) & (US$ Million) Table 136. Europe Eosinophilic Esophagitis Drug Revenue by Type (2021-2026) & (US$ Million) Table 137. Europe Eosinophilic Esophagitis Drug Revenue by Type (2027-2032) & (US$ Million) Table 138. Europe Eosinophilic Esophagitis Drug Sales by Type (2021-2026) & (K Units) Table 139. Europe Eosinophilic Esophagitis Drug Sales by Type (2027-2032) & (K Units) Table 140. Europe Eosinophilic Esophagitis Drug Sales Price by Type (2021-2026) & (USD/Unit) Table 141. Europe Eosinophilic Esophagitis Drug Sales Price by Type (2027-2032) & (USD/Unit) Table 142. Europe Eosinophilic Esophagitis Drug Revenue by Application (2021-2026) & (US$ Million) Table 143. Europe Eosinophilic Esophagitis Drug Revenue by Application (2027-2032) & (US$ Million) Table 144. Europe Eosinophilic Esophagitis Drug Sales by Application (2021-2026) & (K Units) Table 145. Europe Eosinophilic Esophagitis Drug Sales by Application (2027-2032) & (K Units) Table 146. Europe Eosinophilic Esophagitis Drug Sales Price by Application (2021-2026) & (USD/Unit) Table 147. Europe Eosinophilic Esophagitis Drug Sales Price by Application (2027-2032) & (USD/Unit) Table 148. Europe Eosinophilic Esophagitis Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 149. Europe Eosinophilic Esophagitis Drug Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 150. Europe Eosinophilic Esophagitis Drug Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 151. Europe Eosinophilic Esophagitis Drug Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 152. Europe Eosinophilic Esophagitis Drug Sales by Country (2021-2026) & (K Units) Table 153. Europe Eosinophilic Esophagitis Drug Sales by Country (2027-2032) & (K Units) Table 154. Europe Eosinophilic Esophagitis Drug Sales Price by Country (2021-2026) & (USD/Unit) Table 155. Europe Eosinophilic Esophagitis Drug Sales Price by Country (2027-2032) & (USD/Unit) Table 156. Germany Eosinophilic Esophagitis Drug Revenue (2021-2032) & (US$ Million) Table 157. France Eosinophilic Esophagitis Drug Revenue (2021-2032) & (US$ Million) Table 158. U.K. Eosinophilic Esophagitis Drug Revenue (2021-2032) & (US$ Million) Table 159. Italy Eosinophilic Esophagitis Drug Revenue (2021-2032) & (US$ Million) Table 160. Russia Eosinophilic Esophagitis Drug Revenue (2021-2032) & (US$ Million) Table 161. Spain Eosinophilic Esophagitis Drug Revenue (2021-2032) & (US$ Million) Table 162. Netherlands Eosinophilic Esophagitis Drug Revenue (2021-2032) & (US$ Million) Table 163. Switzerland Eosinophilic Esophagitis Drug Revenue (2021-2032) & (US$ Million) Table 164. Sweden Eosinophilic Esophagitis Drug Revenue (2021-2032) & (US$ Million) Table 165. Poland Eosinophilic Esophagitis Drug Revenue (2021-2032) & (US$ Million) Table 166. China Eosinophilic Esophagitis Drug Revenue by Type (2021-2026) & (US$ Million) Table 167. China Eosinophilic Esophagitis Drug Revenue by Type (2027-2032) & (US$ Million) Table 168. China Eosinophilic Esophagitis Drug Sales by Type (2021-2026) & (K Units) Table 169. China Eosinophilic Esophagitis Drug Sales by Type (2027-2032) & (K Units) Table 170. China Eosinophilic Esophagitis Drug Sales Price by Type (2021-2026) & (USD/Unit) Table 171. China Eosinophilic Esophagitis Drug Sales Price by Type (2027-2032) & (USD/Unit) Table 172. China Eosinophilic Esophagitis Drug Revenue by Application (2021-2026) & (US$ Million) Table 173. China Eosinophilic Esophagitis Drug Revenue by Application (2027-2032) & (US$ Million) Table 174. China Eosinophilic Esophagitis Drug Sales by Application (2021-2026) & (K Units) Table 175. China Eosinophilic Esophagitis Drug Sales by Application (2027-2032) & (K Units) Table 176. China Eosinophilic Esophagitis Drug Sales Price by Application (2021-2026) & (USD/Unit) Table 177. China Eosinophilic Esophagitis Drug Sales Price by Application (2027-2032) & (USD/Unit) Table 178. Asia Eosinophilic Esophagitis Drug Revenue by Type (2021-2026) & (US$ Million) Table 179. Asia Eosinophilic Esophagitis Drug Revenue by Type (2027-2032) & (US$ Million) Table 180. Asia Eosinophilic Esophagitis Drug Sales by Type (2021-2026) & (K Units) Table 181. Asia Eosinophilic Esophagitis Drug Sales by Type (2027-2032) & (K Units) Table 182. Asia Eosinophilic Esophagitis Drug Sales Price by Type (2021-2026) & (USD/Unit) Table 183. Asia Eosinophilic Esophagitis Drug Sales Price by Type (2027-2032) & (USD/Unit) Table 184. Asia Eosinophilic Esophagitis Drug Revenue by Application (2021-2026) & (US$ Million) Table 185. Asia Eosinophilic Esophagitis Drug Revenue by Application (2027-2032) & (US$ Million) Table 186. Asia Eosinophilic Esophagitis Drug Sales by Application (2021-2026) & (K Units) Table 187. Asia Eosinophilic Esophagitis Drug Sales by Application (2027-2032) & (K Units) Table 188. Asia Eosinophilic Esophagitis Drug Sales Price by Application (2021-2026) & (USD/Unit) Table 189. Asia Eosinophilic Esophagitis Drug Sales Price by Application (2027-2032) & (USD/Unit) Table 190. Asia Eosinophilic Esophagitis Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 191. Asia Eosinophilic Esophagitis Drug Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 192. Asia Eosinophilic Esophagitis Drug Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 193. Asia Eosinophilic Esophagitis Drug Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 194. Asia Eosinophilic Esophagitis Drug Sales by Country (2021-2026) & (K Units) Table 195. Asia Eosinophilic Esophagitis Drug Sales by Country (2027-2032) & (K Units) Table 196. Asia Eosinophilic Esophagitis Drug Sales Price by Country (2021-2026) & (USD/Unit) Table 197. Asia Eosinophilic Esophagitis Drug Sales Price by Country (2027-2032) & (USD/Unit) Table 198. Japan Eosinophilic Esophagitis Drug Revenue (2021-2032) & (US$ Million) Table 199. South Korea Eosinophilic Esophagitis Drug Revenue (2021-2032) & (US$ Million) Table 200. India Eosinophilic Esophagitis Drug Revenue (2021-2032) & (US$ Million) Table 201. Australia Eosinophilic Esophagitis Drug Revenue (2021-2032) & (US$ Million) Table 202. Taiwan Eosinophilic Esophagitis Drug Revenue (2021-2032) & (US$ Million) Table 203. Southeast Asia Eosinophilic Esophagitis Drug Revenue (2021-2032) & (US$ Million) Table 204. SAMEA Eosinophilic Esophagitis Drug Revenue by Type (2021-2026) & (US$ Million) Table 205. SAMEA Eosinophilic Esophagitis Drug Revenue by Type (2027-2032) & (US$ Million) Table 206. SAMEA Eosinophilic Esophagitis Drug Sales by Type (2021-2026) & (K Units) Table 207. SAMEA Eosinophilic Esophagitis Drug Sales by Type (2027-2032) & (K Units) Table 208. SAMEA Eosinophilic Esophagitis Drug Sales Price by Type (2021-2026) & (USD/Unit) Table 209. SAMEA Eosinophilic Esophagitis Drug Sales Price by Type (2027-2032) & (USD/Unit) Table 210. SAMEA Eosinophilic Esophagitis Drug Revenue by Application (2021-2026) & (US$ Million) Table 211. SAMEA Eosinophilic Esophagitis Drug Revenue by Application (2027-2032) & (US$ Million) Table 212. SAMEA Eosinophilic Esophagitis Drug Sales by Application (2021-2026) & (K Units) Table 213. SAMEA Eosinophilic Esophagitis Drug Sales by Application (2027-2032) & (K Units) Table 214. SAMEA Eosinophilic Esophagitis Drug Sales Price by Application (2021-2026) & (USD/Unit) Table 215. SAMEA Eosinophilic Esophagitis Drug Sales Price by Application (2027-2032) & (USD/Unit) Table 216. SAMEA Eosinophilic Esophagitis Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 217. SAMEA Eosinophilic Esophagitis Drug Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 218. SAMEA Eosinophilic Esophagitis Drug Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 219. SAMEA Eosinophilic Esophagitis Drug Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 220. SAMEA Eosinophilic Esophagitis Drug Sales by Country (2021-2026) & (K Units) Table 221. SAMEA Eosinophilic Esophagitis Drug Sales by Country (2027-2032) & (K Units) Table 222. SAMEA Eosinophilic Esophagitis Drug Sales Price by Country (2021-2026) & (USD/Unit) Table 223. SAMEA Eosinophilic Esophagitis Drug Sales Price by Country (2027-2032) & (USD/Unit) Table 224. Brazil Eosinophilic Esophagitis Drug Revenue (2021-2032) & (US$ Million) Table 225. Argentina Eosinophilic Esophagitis Drug Revenue (2021-2032) & (US$ Million) Table 226. Chile Eosinophilic Esophagitis Drug Revenue (2021-2032) & (US$ Million) Table 227. Colombia Eosinophilic Esophagitis Drug Revenue (2021-2032) & (US$ Million) Table 228. Peru Eosinophilic Esophagitis Drug Revenue (2021-2032) & (US$ Million) Table 229. Saudi Arabia Eosinophilic Esophagitis Drug Revenue (2021-2032) & (US$ Million) Table 230. Israel Eosinophilic Esophagitis Drug Revenue (2021-2032) & (US$ Million) Table 231. UAE Eosinophilic Esophagitis Drug Revenue (2021-2032) & (US$ Million) Table 232. Turkey Eosinophilic Esophagitis Drug Revenue (2021-2032) & (US$ Million) Table 233. Iran Eosinophilic Esophagitis Drug Revenue (2021-2032) & (US$ Million) Table 234. Egypt Eosinophilic Esophagitis Drug Revenue (2021-2032) & (US$ Million) Table 235. Key Raw Materials Table 236. Raw Materials Key Suppliers Table 237. Eosinophilic Esophagitis Drug Distributors List Table 238. Eosinophilic Esophagitis Drug Customers List Table 239. Research Programs/Design for This Report Table 240. Authors List of This Report Table 241. Secondary Sources Table 242. Primary Sources List of Figures Figure 1. Eosinophilic Esophagitis Drug Image Figure 2. Global Eosinophilic Esophagitis Drug Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Eosinophilic Esophagitis Drug Market Size Share 2021 VS 2025 VS 2032 Figure 4. Budesonide Image Figure 5. Fluticasone Image Figure 6. Others Image Figure 7. Global Eosinophilic Esophagitis Drug Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global Eosinophilic Esophagitis Drug Market Size Share 2021 VS 2025 VS 2032 Figure 9. Hospitals Image Figure 10. Clinics Image Figure 11. Drugstore Image Figure 12. Global Eosinophilic Esophagitis Drug Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Eosinophilic Esophagitis Drug Revenue (2021-2032) & (US$ Million) Figure 14. Global Eosinophilic Esophagitis Drug Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 15. Global Eosinophilic Esophagitis Drug Revenue Market Share by Region: 2025 Versus 2032 Figure 16. Global Eosinophilic Esophagitis Drug Revenue Market Share by Region (2021-2032) Figure 17. Global Eosinophilic Esophagitis Drug Sales (2021-2032) & (K Units) Figure 18. Global Eosinophilic Esophagitis Drug Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 19. Global Eosinophilic Esophagitis Drug Sales Market Share by Region (2021-2032) Figure 20. US & Canada & Mexico Eosinophilic Esophagitis Drug Sales YoY (2021-2032) & (K Units) Figure 21. Europe Eosinophilic Esophagitis Drug Sales YoY (2021-2032) & (K Units) Figure 22. China Eosinophilic Esophagitis Drug Sales YoY (2021-2032) & (K Units) Figure 23. Asia (Excluding China) Eosinophilic Esophagitis Drug Sales YoY (2021-2032) & (K Units) Figure 24. South America, Middle East and Africa Eosinophilic Esophagitis Drug Sales YoY (2021-2032) & (K Units) Figure 25. Global Eosinophilic Esophagitis Drug Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 26. Global Eosinophilic Esophagitis Drug Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 27. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 28. Global Eosinophilic Esophagitis Drug Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 29. Global Eosinophilic Esophagitis Drug Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 30. Global Eosinophilic Esophagitis Drug Revenue Market Share by Type (2021-2032) Figure 31. Global Eosinophilic Esophagitis Drug Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 32. Global Eosinophilic Esophagitis Drug Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 33. Global Eosinophilic Esophagitis Drug Sales Market Share by Type (2021-2032) Figure 34. Global Eosinophilic Esophagitis Drug Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 35. Global Eosinophilic Esophagitis Drug Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 36. Global Eosinophilic Esophagitis Drug Revenue Market Share by Application (2021-2032) Figure 37. Global Eosinophilic Esophagitis Drug Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 38. Global Eosinophilic Esophagitis Drug Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 39. Global Eosinophilic Esophagitis Drug Sales Market Share by Application (2021-2032) Figure 40. North America Eosinophilic Esophagitis Drug Revenue Share by Type (2021-2032) Figure 41. North America Eosinophilic Esophagitis Drug Sales Share by Type (2021-2032) Figure 42. North America Eosinophilic Esophagitis Drug Revenue Share by Application (2021-2032) Figure 43. North America Eosinophilic Esophagitis Drug Sales Share by Application (2021-2032) Figure 44. North America Eosinophilic Esophagitis Drug Revenue Share by Country (2021-2032) Figure 45. North America Eosinophilic Esophagitis Drug Sales Share by Country (2021-2032) Figure 46. Europe Eosinophilic Esophagitis Drug Revenue Share by Type (2021-2032) Figure 47. Europe Eosinophilic Esophagitis Drug Sales Share by Type (2021-2032) Figure 48. Europe Eosinophilic Esophagitis Drug Revenue Share by Application (2021-2032) Figure 49. Europe Eosinophilic Esophagitis Drug Sales Share by Application (2021-2032) Figure 50. Europe Eosinophilic Esophagitis Drug Revenue Share by Country (2021-2032) Figure 51. Europe Eosinophilic Esophagitis Drug Sales Share by Country (2021-2032) Figure 52. China Eosinophilic Esophagitis Drug Revenue Share by Type (2021-2032) Figure 53. China Eosinophilic Esophagitis Drug Sales Share by Type (2021-2032) Figure 54. China Eosinophilic Esophagitis Drug Revenue Share by Application (2021-2032) Figure 55. China Eosinophilic Esophagitis Drug Sales Share by Application (2021-2032) Figure 56. Asia Eosinophilic Esophagitis Drug Revenue Share by Type (2021-2032) Figure 57. Asia Eosinophilic Esophagitis Drug Sales Share by Type (2021-2032) Figure 58. Asia Eosinophilic Esophagitis Drug Revenue Share by Application (2021-2032) Figure 59. Asia Eosinophilic Esophagitis Drug Sales Share by Application (2021-2032) Figure 60. Asia Eosinophilic Esophagitis Drug Revenue Share by Country (2021-2032) Figure 61. Asia Eosinophilic Esophagitis Drug Sales Share by Country (2021-2032) Figure 62. SAMEA Eosinophilic Esophagitis Drug Revenue Share by Type (2021-2032) Figure 63. SAMEA Eosinophilic Esophagitis Drug Sales Share by Type (2021-2032) Figure 64. SAMEA Eosinophilic Esophagitis Drug Revenue Share by Application (2021-2032) Figure 65. SAMEA Eosinophilic Esophagitis Drug Sales Share by Application (2021-2032) Figure 66. SAMEA Eosinophilic Esophagitis Drug Revenue Share by Country (2021-2032) Figure 67. SAMEA Eosinophilic Esophagitis Drug Sales Share by Country (2021-2032) Figure 68. Eosinophilic Esophagitis Drug Value Chain Figure 69. Manufacturing Cost Structure Figure 70. Eosinophilic Esophagitis Drug Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Budesonide
  • Fluticasone
  • Others
Applications
  • Hospitals
  • Clinics
  • Drugstore
Companies covered
  • AstraZeneca
  • GSK
  • Bayer
  • Adare Pharmaceuticals
  • DBV Technologies
  • Dr. Falk Pharma
  • Quorum Innovations
  • Takeda
  • Calypso
  • Celgene
  • Regeneron

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Eosinophilic Esophagitis Drug Market by Type
  3. 1.2.1 Global Eosinophilic Esophagitis Drug Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Budesonide
  5. 1.2.3 Fluticasone
  6. 1.2.4 Others
  7. 1.3 Eosinophilic Esophagitis Drug Market by Application
  8. 1.3.1 Global Eosinophilic Esophagitis Drug Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Hospitals
  10. 1.3.3 Clinics
  11. 1.3.4 Drugstore
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 Eosinophilic Esophagitis Drug Market Dynamics
  1. 2.1 Eosinophilic Esophagitis Drug Industry Trends
  2. 2.2 Eosinophilic Esophagitis Drug Industry Drivers
  3. 2.3 Eosinophilic Esophagitis Drug Industry Opportunities and Challenges
  4. 2.4 Eosinophilic Esophagitis Drug Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Eosinophilic Esophagitis Drug Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Eosinophilic Esophagitis Drug Revenue by Region
  3. 3.2.1 Global Eosinophilic Esophagitis Drug Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Eosinophilic Esophagitis Drug Revenue by Region (2021-2026)
  5. 3.2.3 Global Eosinophilic Esophagitis Drug Revenue by Region (2027-2032)
  6. 3.2.4 Global Eosinophilic Esophagitis Drug Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Eosinophilic Esophagitis Drug Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Eosinophilic Esophagitis Drug Sales by Region
  9. 3.4.1 Global Eosinophilic Esophagitis Drug Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Eosinophilic Esophagitis Drug Sales by Region (2021-2026)
  11. 3.4.3 Global Eosinophilic Esophagitis Drug Sales by Region (2027-2032)
  12. 3.4.4 Global Eosinophilic Esophagitis Drug Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Eosinophilic Esophagitis Drug Revenue by Manufacturers
  2. 4.1.1 Global Eosinophilic Esophagitis Drug Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Eosinophilic Esophagitis Drug Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Eosinophilic Esophagitis Drug Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Eosinophilic Esophagitis Drug Sales by Manufacturers
  6. 4.2.1 Global Eosinophilic Esophagitis Drug Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Eosinophilic Esophagitis Drug Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Eosinophilic Esophagitis Drug Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Eosinophilic Esophagitis Drug Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Eosinophilic Esophagitis Drug Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Eosinophilic Esophagitis Drug Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Eosinophilic Esophagitis Drug Manufacturers, Product Type & Application
  13. 4.7 Global Eosinophilic Esophagitis Drug Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Eosinophilic Esophagitis Drug Market CR5 and HHI
  16. 4.8.2 2025 Eosinophilic Esophagitis Drug Tier 1, Tier 2, and Tier 3
5 Eosinophilic Esophagitis Drug Market by Type
  1. 5.1 Global Eosinophilic Esophagitis Drug Revenue by Type
  2. 5.1.1 Global Eosinophilic Esophagitis Drug Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Eosinophilic Esophagitis Drug Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Eosinophilic Esophagitis Drug Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Eosinophilic Esophagitis Drug Sales by Type
  6. 5.2.1 Global Eosinophilic Esophagitis Drug Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Eosinophilic Esophagitis Drug Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global Eosinophilic Esophagitis Drug Sales Market Share by Type (2021-2032)
  9. 5.3 Global Eosinophilic Esophagitis Drug Price by Type
6 Eosinophilic Esophagitis Drug Market by Application
  1. 6.1 Global Eosinophilic Esophagitis Drug Revenue by Application
  2. 6.1.1 Global Eosinophilic Esophagitis Drug Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Eosinophilic Esophagitis Drug Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Eosinophilic Esophagitis Drug Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Eosinophilic Esophagitis Drug Sales by Application
  6. 6.2.1 Global Eosinophilic Esophagitis Drug Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Eosinophilic Esophagitis Drug Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global Eosinophilic Esophagitis Drug Sales Market Share by Application (2021-2032)
  9. 6.3 Global Eosinophilic Esophagitis Drug Price by Application
7 Company Profiles
  1. 7.1 AstraZeneca
  2. 7.1.1 AstraZeneca Company Information
  3. 7.1.2 AstraZeneca Business Overview
  4. 7.1.3 AstraZeneca Eosinophilic Esophagitis Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 AstraZeneca Eosinophilic Esophagitis Drug Product Portfolio
  6. 7.1.5 AstraZeneca Recent Developments
  7. 7.2 GSK
  8. 7.2.1 GSK Company Information
  9. 7.2.2 GSK Business Overview
  10. 7.2.3 GSK Eosinophilic Esophagitis Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 GSK Eosinophilic Esophagitis Drug Product Portfolio
  12. 7.2.5 GSK Recent Developments
  13. 7.3 Bayer
  14. 7.3.1 Bayer Company Information
  15. 7.3.2 Bayer Business Overview
  16. 7.3.3 Bayer Eosinophilic Esophagitis Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Bayer Eosinophilic Esophagitis Drug Product Portfolio
  18. 7.3.5 Bayer Recent Developments
  19. 7.4 Adare Pharmaceuticals
  20. 7.4.1 Adare Pharmaceuticals Company Information
  21. 7.4.2 Adare Pharmaceuticals Business Overview
  22. 7.4.3 Adare Pharmaceuticals Eosinophilic Esophagitis Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Adare Pharmaceuticals Eosinophilic Esophagitis Drug Product Portfolio
  24. 7.4.5 Adare Pharmaceuticals Recent Developments
  25. 7.5 DBV Technologies
  26. 7.5.1 DBV Technologies Company Information
  27. 7.5.2 DBV Technologies Business Overview
  28. 7.5.3 DBV Technologies Eosinophilic Esophagitis Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 DBV Technologies Eosinophilic Esophagitis Drug Product Portfolio
  30. 7.5.5 DBV Technologies Recent Developments
  31. 7.6 Dr. Falk Pharma
  32. 7.6.1 Dr. Falk Pharma Company Information
  33. 7.6.2 Dr. Falk Pharma Business Overview
  34. 7.6.3 Dr. Falk Pharma Eosinophilic Esophagitis Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Dr. Falk Pharma Eosinophilic Esophagitis Drug Product Portfolio
  36. 7.6.5 Dr. Falk Pharma Recent Developments
  37. 7.7 Quorum Innovations
  38. 7.7.1 Quorum Innovations Company Information
  39. 7.7.2 Quorum Innovations Business Overview
  40. 7.7.3 Quorum Innovations Eosinophilic Esophagitis Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Quorum Innovations Eosinophilic Esophagitis Drug Product Portfolio
  42. 7.7.5 Quorum Innovations Recent Developments
  43. 7.8 Takeda
  44. 7.8.1 Takeda Company Information
  45. 7.8.2 Takeda Business Overview
  46. 7.8.3 Takeda Eosinophilic Esophagitis Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Takeda Eosinophilic Esophagitis Drug Product Portfolio
  48. 7.8.5 Takeda Recent Developments
  49. 7.9 Calypso
  50. 7.9.1 Calypso Company Information
  51. 7.9.2 Calypso Business Overview
  52. 7.9.3 Calypso Eosinophilic Esophagitis Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Calypso Eosinophilic Esophagitis Drug Product Portfolio
  54. 7.9.5 Calypso Recent Developments
  55. 7.10 Celgene
  56. 7.10.1 Celgene Company Information
  57. 7.10.2 Celgene Business Overview
  58. 7.10.3 Celgene Eosinophilic Esophagitis Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Celgene Eosinophilic Esophagitis Drug Product Portfolio
  60. 7.10.5 Celgene Recent Developments
  61. 7.11 Regeneron
  62. 7.11.1 Regeneron Company Information
  63. 7.11.2 Regeneron Business Overview
  64. 7.11.3 Regeneron Eosinophilic Esophagitis Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 Regeneron Eosinophilic Esophagitis Drug Product Portfolio
  66. 7.11.5 Regeneron Recent Developments
8 North America
  1. 8.1 North America Eosinophilic Esophagitis Drug Market Size by Type
  2. 8.1.1 North America Eosinophilic Esophagitis Drug Revenue by Type (2021-2032)
  3. 8.1.2 North America Eosinophilic Esophagitis Drug Sales by Type (2021-2032)
  4. 8.1.3 North America Eosinophilic Esophagitis Drug Price by Type (2021-2032)
  5. 8.2 North America Eosinophilic Esophagitis Drug Market Size by Application
  6. 8.2.1 North America Eosinophilic Esophagitis Drug Revenue by Application (2021-2032)
  7. 8.2.2 North America Eosinophilic Esophagitis Drug Sales by Application (2021-2032)
  8. 8.2.3 North America Eosinophilic Esophagitis Drug Price by Application (2021-2032)
  9. 8.3 North America Eosinophilic Esophagitis Drug Market Size by Country
  10. 8.3.1 North America Eosinophilic Esophagitis Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Eosinophilic Esophagitis Drug Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Eosinophilic Esophagitis Drug Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Eosinophilic Esophagitis Drug Market Size by Type
  2. 9.1.1 Europe Eosinophilic Esophagitis Drug Revenue by Type (2021-2032)
  3. 9.1.2 Europe Eosinophilic Esophagitis Drug Sales by Type (2021-2032)
  4. 9.1.3 Europe Eosinophilic Esophagitis Drug Price by Type (2021-2032)
  5. 9.2 Europe Eosinophilic Esophagitis Drug Market Size by Application
  6. 9.2.1 Europe Eosinophilic Esophagitis Drug Revenue by Application (2021-2032)
  7. 9.2.2 Europe Eosinophilic Esophagitis Drug Sales by Application (2021-2032)
  8. 9.2.3 Europe Eosinophilic Esophagitis Drug Price by Application (2021-2032)
  9. 9.3 Europe Eosinophilic Esophagitis Drug Market Size by Country
  10. 9.3.1 Europe Eosinophilic Esophagitis Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Eosinophilic Esophagitis Drug Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Eosinophilic Esophagitis Drug Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Eosinophilic Esophagitis Drug Market Size by Type
  2. 10.1.1 China Eosinophilic Esophagitis Drug Revenue by Type (2021-2032)
  3. 10.1.2 China Eosinophilic Esophagitis Drug Sales by Type (2021-2032)
  4. 10.1.3 China Eosinophilic Esophagitis Drug Price by Type (2021-2032)
  5. 10.2 China Eosinophilic Esophagitis Drug Market Size by Application
  6. 10.2.1 China Eosinophilic Esophagitis Drug Revenue by Application (2021-2032)
  7. 10.2.2 China Eosinophilic Esophagitis Drug Sales by Application (2021-2032)
  8. 10.2.3 China Eosinophilic Esophagitis Drug Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Eosinophilic Esophagitis Drug Market Size by Type
  2. 11.1.1 Asia Eosinophilic Esophagitis Drug Revenue by Type (2021-2032)
  3. 11.1.2 Asia Eosinophilic Esophagitis Drug Sales by Type (2021-2032)
  4. 11.1.3 Asia Eosinophilic Esophagitis Drug Price by Type (2021-2032)
  5. 11.2 Asia Eosinophilic Esophagitis Drug Market Size by Application
  6. 11.2.1 Asia Eosinophilic Esophagitis Drug Revenue by Application (2021-2032)
  7. 11.2.2 Asia Eosinophilic Esophagitis Drug Sales by Application (2021-2032)
  8. 11.2.3 Asia Eosinophilic Esophagitis Drug Price by Application (2021-2032)
  9. 11.3 Asia Eosinophilic Esophagitis Drug Market Size by Country
  10. 11.3.1 Asia Eosinophilic Esophagitis Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Eosinophilic Esophagitis Drug Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Eosinophilic Esophagitis Drug Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Eosinophilic Esophagitis Drug Market Size by Type
  2. 12.1.1 SAMEA Eosinophilic Esophagitis Drug Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Eosinophilic Esophagitis Drug Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Eosinophilic Esophagitis Drug Price by Type (2021-2032)
  5. 12.2 SAMEA Eosinophilic Esophagitis Drug Market Size by Application
  6. 12.2.1 SAMEA Eosinophilic Esophagitis Drug Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Eosinophilic Esophagitis Drug Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Eosinophilic Esophagitis Drug Price by Application (2021-2032)
  9. 12.3 SAMEA Eosinophilic Esophagitis Drug Market Size by Country
  10. 12.3.1 SAMEA Eosinophilic Esophagitis Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Eosinophilic Esophagitis Drug Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Eosinophilic Esophagitis Drug Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Eosinophilic Esophagitis Drug Value Chain Analysis
  2. 13.1.1 Eosinophilic Esophagitis Drug Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Eosinophilic Esophagitis Drug Production Mode & Process
  6. 13.2 Eosinophilic Esophagitis Drug Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Eosinophilic Esophagitis Drug Distributors
  9. 13.2.3 Eosinophilic Esophagitis Drug Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst